Paraneoplastic dermatomyositis appearing after nivolumab therapy for gastric cancer: a case report-Reference-Cited by-同舟云学术

Paraneoplastic dermatomyositis appearing after nivolumab therapy for gastric cancer: a case report

Published:2019-06-02 Issue:1 Volume:13 Page:
ISSN:1752-1947
Container-title:Journal of Medical Case Reports
language:en
Short-container-title:J Med Case Reports

Author:

Shibata Chikako,Kato Jun,Toda Nobuo,Imai Makoto,Fukumura Yukiyo,Arai Junya,Kurokawa Ken,Kondo Mayuko,Takagi Kaoru,Kojima Kentaro,Ohki Takamasa,Seki Michiharu,Yoshida Masanobu,Suzuki Akitake,Tagawa Kazumi

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s13256-019-2105-9.pdf

Reference17 articles.

1. Bukhari M. Drug-induced rheumatic diseases: a review of published case reports from the last two years. Curr Opin Rheumatol. 2012;24(2):182–6.

2. Johnson DB, Balko JM, Compton ML, Chalkias S, Gorham J, Xu Y, et al. Fulminant Myocarditis with Combination Immune Checkpoint Blockade. N Engl J Med. 2016;375(18):1749–55.

3. Iwai Y, Ishida M, Tanaka Y, Okazaki T, Honjo T, Minato N. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade. Proc Natl Acad Sci U S A. 2002;99(19):12293–7.

4. Rui Y, Honjo T, Chikuma S. Programmed cell death 1 inhibits inflammatory helper T-cell development through controlling the innate immune response. Proc Natl Acad Sci U S A. 2013;110(40):16073–8.

5. Weber JS, Postow M, Lao CD, Schadendorf D. Management of Adverse Events Following Treatment With Anti-Programmed Death-1 Agents. Oncologist. 2016;21(10):1230–40.

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating the disparities among drug categories in drug-induced dermatomyositis: A systematic review;Seminars in Arthritis and Rheumatism;2024-08

2. A case of dermatomyositis associated with atezolizumab plus bevacizumab therapy for advanced hepatocellular carcinoma;Kanzo;2024-07-01

3. Causes and Clinical Presentation of Drug-Induced Dermatomyositis;JAMA Dermatology;2024-02-01

4. Exploring the molecular mechanisms and shared gene signatures between dermatomyositis and gastric cancer;2024-01-24

5. Clinical features of dermatomyositis patients with anti-TIF1 antibodies: A case based comprehensive review;Autoimmunity Reviews;2023-12